Добірка наукової літератури з теми "IgE mediated allergy"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "IgE mediated allergy".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "IgE mediated allergy"
Białek, Sławomir, and Katarzyna Białek-Gosk. "Modern diagnosis of IgE-mediated allergy – molecular diagnosis of allergies." Diagnostyka Laboratoryjna 52, no. 1 (April 18, 2016): 45–50. http://dx.doi.org/10.5604/01.3001.0008.9630.
Повний текст джерелаZhang, PeiAo, Jihui Gao, Huilian Che, Wentong Xue, and Dong Yang. "Molecular Basis of IgE-Mediated Shrimp Allergy and Heat Desensitization." Nutrients 13, no. 10 (September 27, 2021): 3397. http://dx.doi.org/10.3390/nu13103397.
Повний текст джерелаCianferoni, Antonella. "Non-IgE Mediated Food Allergy." Current Pediatric Reviews 16, no. 2 (July 1, 2020): 95–105. http://dx.doi.org/10.2174/1573396315666191031103714.
Повний текст джерелаCianferoni, Antonella. "Non-IgE Mediated Food Allergy." Current Pediatric Reviews 16, no. 2 (May 2020): 95–105. http://dx.doi.org/10.2174/157339631566619103110371.
Повний текст джерелаWei, Tianhao. "Pathological Mechanisms Underlying IgE-mediated Food Allergy." Highlights in Science, Engineering and Technology 2 (June 22, 2022): 230–34. http://dx.doi.org/10.54097/hset.v2i.578.
Повний текст джерелаAnvari, Sara, Jennifer Miller, Chih-Yin Yeh, and Carla M. Davis. "IgE-Mediated Food Allergy." Clinical Reviews in Allergy & Immunology 57, no. 2 (October 29, 2018): 244–60. http://dx.doi.org/10.1007/s12016-018-8710-3.
Повний текст джерелаCalhoun, Karen H., and Minka L. Schofield. "IgE-mediated food allergy." Current Opinion in Otolaryngology & Head and Neck Surgery 18, no. 3 (June 2010): 182–86. http://dx.doi.org/10.1097/moo.0b013e328339530e.
Повний текст джерелаSatyaraj, Ebenezer, Peichuan Sun, and Scott Sherrill. "Fel d1 Blocking Antibodies: A Novel Method to Reduce IgE-Mediated Allergy to Cats." Journal of Immunology Research 2021 (June 19, 2021): 1–7. http://dx.doi.org/10.1155/2021/5545173.
Повний текст джерелаShreffler, Wayne G. "Pathophysiology of immunoglobulin E‐mediated food allergy." Journal of Food Allergy 2, no. 1 (September 1, 2020): 7–10. http://dx.doi.org/10.2500/jfa.2020.2.200024.
Повний текст джерелаPontone, Matteo, Mattia Giovannini, Simona Barni, Francesca Mori, Elisabetta Venturini, Luisa Galli, Claudia Valleriani, et al. "IgE-mediated Anisakis allergy in children." Allergologia et Immunopathologia 51, no. 1 (January 1, 2023): 98–109. http://dx.doi.org/10.15586/aei.v51i1.692.
Повний текст джерелаДисертації з теми "IgE mediated allergy"
Grönlund, Hans. "Diagnosis and treatment of IgE-mediated allergy : new approaches using recombinant allergens /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-373-6/.
Повний текст джерелаPalosuo, Kati. "IgE-mediated allergy to dietary gliadin studies on wheat-dependent, exercise-induced anaphylaxis and childhood wheat allergy." Helsinki : University of Helsinki, 2003. http://ethesis.helsinki.fi/julkaisut/laa/kliin/vk/palosuo/.
Повний текст джерелаMarknell, DeWitt Åsa. "Use of Recombinant Allergens for Component-Resolved Diagnostics (CRD) in IgE-Mediated Allergy." Doctoral thesis, Uppsala University, Department of Medical Biochemistry and Microbiology, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7813.
Повний текст джерелаImmunoglobulin E (IgE)-mediated allergy occurs when our immune system causes a reaction to otherwise harmless substances (allergens). Allergens are predominantly proteins present in biological materials such as pollens, mites, animal epithelia, moulds and foods.
In vitro tests for specific IgE antibodies usually employ an allergen source extract as an antibody capturing reagent. The proportion of allergenic molecules in these biochemically complex extracts may vary.
Recombinant allergens may be obtained in large quantities with biotechnological techniques. These proteins can be characterized biochemically and immunologically, resulting in tests with minimal batch-to-batch variation. This thesis describes different uses of recombinant allergens in component-resolved diagnostics (CRD).
In CRD, single allergenic proteins are used to establish a sensitization profile of the patient. Two timothy grass (Phleum pratense) pollen allergens, Phl p 11 and Phl p 4, were cloned and expressed as recombinant proteins. They were subsequently characterized and can, for example, be used in a panel for grass pollen CRD.
Single allergens may be useful as diagnostic markers for allergic sensitization. This phenomenon was studied using tropomyosin, a major allergen from the shrimp Penaeus aztecus (Pen a 1). The characteristics of the recombinant and natural proteins were compared. The recombinant tropomyosin was then extensively tested using specific competition for IgE binding against extracts of other crustacean species, house dust mite and cockroach.
In cases when an important allergen is missing or underrepresented in a natural extract, the corresponding recombinant allergen may be added to the extract as a spiking reagent. Previous studies have shown that latex extracts for diagnostic testing may lack the allergen Hev b 5. Recombinant Hev b 5 was expressed from a synthetic gene construct, incorporating several adaptations to enable efficient large scale production of the recombinant protein, to be used as a spiking reagent.
Marknell, DeWitt Åsa. "Use of recombinant allergens for component-resolved diagnostics (CRD) in IgE-mediated allergy /." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-7813.
Повний текст джерелаYamani, Amnah. "Dysregulation of Vascular Endothelial Function Modulates Severity of IgE-mediated Anaphylactic Reactions." University of Cincinnati / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1490350649626552.
Повний текст джерелаYahya, Mohd Norhakim. "Analysis of the IgE network : inhibition of CD23-mediated IgE upregulation and CD21/C3d interaction." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:bc5ff165-2d2c-4e4f-a0e9-5651cacd2ddf.
Повний текст джерелаGray, Claudia Liesel. "The prevalence and patterns of IgE-mediated food allergy and sensitisation in South African children with atopic dermatitis." Doctoral thesis, University of Cape Town, 2014. http://hdl.handle.net/11427/12874.
Повний текст джерелаBackground: The prevalence of food allergy in South Africa is unknown, but previously thought to be low, particularly in black South Africans. We hypothesised that food allergies would be low in Xhosa patients, even those at increased risk of food allergy such as children with atopic dermatitis (AD). This study aimed to determine the prevalence of, patterns and risk factors for, IgE-mediated food allergy in South African children with moderate to severe AD. It is the first food allergy prevalence study in South Africa to utilise controlled food challenges and component analysis, and is unique for its comparison of food allergy patterns between ethnic groups in the same geographical area. Methodology: This was a prospective, observational study in a paediatric university hospital in Cape Town. Children with moderate to severe AD, aged 6 months to 10 years, were randomly recruited from the dermatology clinic. They were assessed for sensitisation and allergy by questionnaire, skin prick tests (SPT), Immuno Solid Phase Allergen Chip (ISAC) test and incremental food challenges. Sensitised patients were also tested for specific IgE by ImmunoCAP test. Results: One hundred participants (59 black Africans and 41 of mixed race) were enrolled, median age 42 months. There were high overall rates of food sensitisation (66%) and food allergy (40%). Egg (25%) and peanut (24%) were the most common allergies. Black participants had comparable sensitisation (69% vs 61%) but lower allergy rates (34% vs 46%) than mixed race participants. This was especially evident for peanut allergy (15% vs 37%, p=0.01). Early onset AD (< 6 months), severe eczema, and young age < 2 years were significant risk factors for food allergy. The ISAC test was less sensitive than SPT and ImmunoCAP tests. Only 42% of cases of perceived food allergy were confirmed as true food allergy.
Rolf, Sofia, and Johanna Svensson. "Den dolda funktionsnedsättningen – att leva med IgE-medierad födoämnesallergi : Erfarenheter och uppfattningar av att leva med en folksjukdom." Thesis, Högskolan i Halmstad, Akademin för hälsa och välfärd, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:hh:diva-36067.
Повний текст джерелаFood allergy is a hidden disability that does not become visible until the individual develops an allergic reaction. From there on it can quickly become a matter of life or death. The physical response has been well researched and yet how the disease affects the patient’s life situation is relatively unexploded. Nursing literature regarding allergy risks and interventions mention little about food allergy. The aim of the study was therefore to highlight patients’ experiences and perceptions of living with IgE-mediated food allergy. Through a literature study four themes emerged: Fear and loss of security, Managing everyday life, Importance of information regarding labeling of food and The importance of support from others. The experience of not having control, a constant risk of unsuspected reactions, not always having an understanding from others and having to defend their needs gave a negative emotional response. The way back to an ordinary living consisted of strategies, understanding and reconciliation, yet there were still obstacles left in the environment. The knowledge of this study can be used in caring for a food allergic patient without jeopardizing healing process and feeling of security. The society needs to meet the patient group’s needs through adaptation, to achieve quality of life.
Larsson, Anna-Karin. "Early life cytokines, viral infections and IgE-mediated allergic disease." Doctoral thesis, Stockholm : Wenner-Gren Institute for Experimental Biology, Stockholm university, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-1224.
Повний текст джерелаPowe, Desmond George. "Do some subjects with idiopathic rhinitis have an allergic inflammatory disease mediated by IgE, in their nasal mucosa?" Thesis, University of Nottingham, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.408604.
Повний текст джерелаКниги з теми "IgE mediated allergy"
Puntis, John. Food allergy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198759928.003.0019.
Повний текст джерелаBeattie, R. Mark, Anil Dhawan, and John W.L. Puntis. Eosinophilic disorders. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780198569862.003.0045.
Повний текст джерелаMisbah, Siraj. Suspected anaphylaxis. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0075.
Повний текст джерелаЧастини книг з теми "IgE mediated allergy"
Urbanek, R. "IgE-Mediated Allergies." In Food Allergy in Infancy and Childhood, 133–37. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-74357-3_13.
Повний текст джерелаSicherer, Scott H. "IgE- and Non-IgE-Mediated Food Allergy." In Eosinophilic Esophagitis, 219–38. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-515-6_16.
Повний текст джерелаBischoff, Stephan C., and Gernot Sellge. "The Immunological Basis of IgE-Mediated Reactions." In Food Allergy, 16–30. Chichester, UK: John Wiley & Sons Ltd, 2014. http://dx.doi.org/10.1002/9781118744185.ch2.
Повний текст джерелаUzzaman, Ashraf, and Hirsh D. Komarow. "The Immunological Basis of Non-IgE-Mediated Reactions." In Food Allergy, 31–46. Chichester, UK: John Wiley & Sons Ltd, 2014. http://dx.doi.org/10.1002/9781118744185.ch3.
Повний текст джерелаFleischer, David M., and Donald Y. M. Leung. "Cutaneous Reactions: Atopic Dermatitis and Other IgE- and Non-IgE-Mediated Skin Reactions." In Food Allergy, 144–57. Chichester, UK: John Wiley & Sons Ltd, 2014. http://dx.doi.org/10.1002/9781118744185.ch11.
Повний текст джерелаWeidinger, Stephan, J. Ring, and F. M. Köhn. "IgE-Mediated Allergy against Human Seminal Plasma." In Chemical Immunology and Allergy, 2005, 128–38. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000087830.
Повний текст джерелаFuchs, T., R. Wahl, and J. Geier. "Immediate-Type Reactions to Rubber Products: IgE Mediated?" In New Trends in Allergy III, 431–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-46717-2_57.
Повний текст джерелаAgostoni, Carlo, and Verduci Elvira. "Growth of Infants with IgE-Mediated Cow’s Milk Allergy." In Handbook of Growth and Growth Monitoring in Health and Disease, 1911–20. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1795-9_115.
Повний текст джерелаKhan, Mahejibin, and Nidhi Sori. "Diet-Gut Microbiota-Brain Axis and IgE-Mediated Food Allergy." In Microbiome-Gut-Brain Axis, 153–68. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-1626-6_6.
Повний текст джерелаCampi, Paolo, Mariangela Manfredi, and Maurizio Severino. "IgE-Mediated Allergy to Pyrazolones, Quinolones and Other Non- &Bg;; -Lactam Antibiotics." In Drug Hypersensitivity, 216–32. Basel: KARGER, 2007. http://dx.doi.org/10.1159/000104202.
Повний текст джерелаТези доповідей конференцій з теми "IgE mediated allergy"
Shabana, H., and M. Askar. "Non-Ige-Mediated Food Allergy May be the Cause of Chronic Bloody Diarrhea." In ESGE Days 2021. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1724665.
Повний текст джерелаIrina-Veronica, Costache, and Plesca Doina Anca. "P26 Case report: severe ige-mediated cow’s milk protein allergy in a salmonella carrier." In 8th Europaediatrics Congress jointly held with, The 13th National Congress of Romanian Pediatrics Society, 7–10 June 2017, Palace of Parliament, Romania, Paediatrics building bridges across Europe. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313273.114.
Повний текст джерелаWeinbrand-Goichberg, Jenny, Shira Benor, Menahem Rottem, Nitzan Shacham, Avigdor Mandelberg, Arie Levine, Koby Sade, Shmuel Kivity, and Ilan Dalal. "P9 Long term outcomes following baked milk – containing diet for ige-mediated milk allergy." In 8th Europaediatrics Congress jointly held with, The 13th National Congress of Romanian Pediatrics Society, 7–10 June 2017, Palace of Parliament, Romania, Paediatrics building bridges across Europe. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313273.97.
Повний текст джерелаFumagalli, Mara, Laura Gianolio, Vania Giacomet, and Gian Vincenzo Zuccotti. "261 Infant hematemesis: a challenging diagnosis, postnatal CMV infection or non IgE-mediated cow’s milk protein allergy? A two case report comparison." In 10th Europaediatrics Congress, Zagreb, Croatia, 7–9 October 2021. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2021. http://dx.doi.org/10.1136/archdischild-2021-europaediatrics.261.
Повний текст джерелаKishida, Tsunao, Yayoi Hiromura, Takemitsu Hama, Jiro Imanishi, Yasuo Hisa, and Osam Mazda. "Interleukin-21 as an Effective Suppressant for IgE-mediated Allergic Hypersensitivity Reactions." In 2007 International Symposium on Micro-NanoMechatronics and Human Science. IEEE, 2007. http://dx.doi.org/10.1109/mhs.2007.4420871.
Повний текст джерелаFassakhov, Rustem, and Sergei Boichuk. "Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2050.
Повний текст джерелаMilgrom, H., J. Fink, A. Fowler-Taylor, C. Fernandez Vidaurre, M. Blogg, and H. Fox. "Safety of Omalizumab in Children with Inadequately Controlled Moderate–Severe Allergic (IgE-Mediated) Asthma." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2809.
Повний текст джерелаGouder, Caroline, Rachelle Asciak, and Stephen Montefort. "The 'real-life' long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa4115.
Повний текст джерелаMilgrom, H., RL Wasserman, A. Fowler-Taylor, C. Fernandez Vidaurre, M. Blogg, and H. Fox. "Add-On Omalizumab Significantly Reduces Exacerbation Rates in Children with Inadequately Controlled Moderate–Severe Allergic (IgE-Mediated) Asthma." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2767.
Повний текст джерелаSimons, Anneliese, Karen Regan, Abid Aziz, and Dinesh Saralaya. "Real-life Effectiveness Of Omalizumab In Patients With Severe Persistent Allergic (IgE-Mediated) Asthma At A Single UK Hospital." In American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans. American Thoracic Society, 2010. http://dx.doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1336.
Повний текст джерела